{"id":14960,"date":"2026-06-10T13:07:12","date_gmt":"2026-06-10T13:07:12","guid":{"rendered":"https:\/\/csiag.de\/?page_id=14960"},"modified":"2026-06-10T13:40:55","modified_gmt":"2026-06-10T13:40:55","slug":"demo-visualisierer","status":"publish","type":"page","link":"https:\/\/csiag.de\/fi\/demo-visualisierer\/","title":{"rendered":"Demo &#8211; Visualisierer"},"content":{"rendered":"<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Lukuaika<\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">Minuutti<\/span><\/span>\n<div style=\"font-family:-apple-system,BlinkMacSystemFont,'Segoe UI',Helvetica,Arial,sans-serif;max-width:960px;margin:0 auto 20px;box-sizing:border-box\">\n\n  <div style=\"background:#fff;border-radius:10px;border:1.5px solid #dde3ea;padding:24px 28px;box-shadow:0 2px 10px rgba(24,95,165,.07);margin-bottom:16px\">\n    <h2 style=\"font-size:15px;font-weight:700;color:#1a3a6b;margin:0 0 8px;letter-spacing:-.01em\">Wissenschaftlich valides Bildungs- und Planungswerkzeug f&#252;r die Onkologie<\/h2>\n    <p style=\"font-size:13.5px;color:#444;line-height:1.7;margin:0 0 10px\">\n      Dieser Visualisierer stellt klinisch relevante Chemotherapie-Parameter interaktiv und tagesgenau dar &#8212; auf Basis validierter FDA Prescribing Information, EORTC- und ASCO-Leitlinien sowie publizierter pharmakologischer Daten.\n    <\/p>\n    <p style=\"font-size:13.5px;color:#444;line-height:1.7;margin:0 0 12px\">\n      W&#228;hlen Sie unten eines der vier vordefinierten Szenarien oder laden Sie &#252;ber <strong>Indikation&thinsp;\/&thinsp;Schema<\/strong> eines der 33 hinterlegten Therapieschemata. Alle Panels aktualisieren sich automatisch.\n    <\/p>\n    <div>\n      <span style=\"display:inline-block;padding:3px 10px;border-radius:12px;font-size:11px;font-weight:700;background:#E6F1FB;color:#0C447C;border:1px solid #85B7EB;margin:0 4px 4px 0\">60 Wirkstoffe<\/span>\n      <span style=\"display:inline-block;padding:3px 10px;border-radius:12px;font-size:11px;font-weight:700;background:#E6F1FB;color:#0C447C;border:1px solid #85B7EB;margin:0 4px 4px 0\">33 Therapieschemata<\/span>\n      <span style=\"display:inline-block;padding:3px 10px;border-radius:12px;font-size:11px;font-weight:700;background:#E6F1FB;color:#0C447C;border:1px solid #85B7EB;margin:0 4px 4px 0\">FN-Risiko<\/span>\n      <span style=\"display:inline-block;padding:3px 10px;border-radius:12px;font-size:11px;font-weight:700;background:#E6F1FB;color:#0C447C;border:1px solid #85B7EB;margin:0 4px 4px 0\">Antiemese<\/span>\n      <span style=\"display:inline-block;padding:3px 10px;border-radius:12px;font-size:11px;font-weight:700;background:#E6F1FB;color:#0C447C;border:1px solid #85B7EB;margin:0 4px 4px 0\">TLS-Risiko<\/span>\n      <span style=\"display:inline-block;padding:3px 10px;border-radius:12px;font-size:11px;font-weight:700;background:#E6F1FB;color:#0C447C;border:1px solid #85B7EB;margin:0 4px 4px 0\">Pharmakogenetik<\/span>\n      <span style=\"display:inline-block;padding:3px 10px;border-radius:12px;font-size:11px;font-weight:700;background:#E6F1FB;color:#0C447C;border:1px solid #85B7EB;margin:0 4px 4px 0\">Dosisanpassung Leber \/ Niere<\/span>\n      <span style=\"display:inline-block;padding:3px 10px;border-radius:12px;font-size:11px;font-weight:700;background:#E6F1FB;color:#0C447C;border:1px solid #85B7EB;margin:0 4px 4px 0\">Ototoxizit&#228;t<\/span>\n      <span style=\"display:inline-block;padding:3px 10px;border-radius:12px;font-size:11px;font-weight:700;background:#E6F1FB;color:#0C447C;border:1px solid #85B7EB;margin:0 4px 4px 0\">PK-Kurven<\/span>\n      <span style=\"display:inline-block;padding:3px 10px;border-radius:12px;font-size:11px;font-weight:700;background:#E6F1FB;color:#0C447C;border:1px solid #85B7EB;margin:0 4px 4px 0\">PDF-Export<\/span>\n    <\/div>\n  <\/div>\n\n  <div style=\"background:#1a3a6b;color:#fff;border-radius:8px;padding:14px 20px;font-size:13px;line-height:1.6\">\n    Lizenzanfragen und weitere Informationen:\n    <a href=\"mailto:info@csiag.de\" style=\"color:#7EB8F7;text-decoration:none;font-weight:600\">info@csiag.de<\/a>\n    &nbsp;&#8212;&nbsp; csiag.de\n    <div style=\"font-size:11px;color:rgba(255,255,255,.55);margin-top:6px\">\n      Kein zugelassenes Medizinprodukt. Dient ausschlie&#223;lich der Weiterbildung und Therapieplanung. Ersetzt nicht die individuelle &#228;rztliche Entscheidung.\n    <\/div>\n  <\/div>\n\n<\/div>","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Lukuaika<\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">Minuutti<\/span><\/span>Wissenschaftlich valides Bildungs- und Planungswerkzeug f&#252;r die Onkologie Dieser Visualisierer stellt klinisch relevante Chemotherapie-Parameter interaktiv und tagesgenau dar &#8212; auf Basis validierter FDA Prescribing Information, EORTC- und ASCO-Leitlinien sowie publizierter pharmakologischer Daten. W&#228;hlen Sie unten eines der vier vordefinierten Szenarien oder laden Sie &#252;ber Indikation&thinsp;\/&thinsp;Schema eines der 33 hinterlegten Therapieschemata. Alle Panels aktualisieren sich automatisch.&hellip;&nbsp;<a href=\"https:\/\/csiag.de\/fi\/demo-visualisierer\/\" rel=\"bookmark\">Lue lis\u00e4\u00e4 \"<span class=\"screen-reader-text\">Demo &#8211; Visualisierer<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"on","neve_meta_disable_footer":"on","neve_meta_disable_title":"off","footnotes":""},"class_list":["post-14960","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/csiag.de\/fi\/wp-json\/wp\/v2\/pages\/14960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/csiag.de\/fi\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/csiag.de\/fi\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/csiag.de\/fi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csiag.de\/fi\/wp-json\/wp\/v2\/comments?post=14960"}],"version-history":[{"count":6,"href":"https:\/\/csiag.de\/fi\/wp-json\/wp\/v2\/pages\/14960\/revisions"}],"predecessor-version":[{"id":14968,"href":"https:\/\/csiag.de\/fi\/wp-json\/wp\/v2\/pages\/14960\/revisions\/14968"}],"wp:attachment":[{"href":"https:\/\/csiag.de\/fi\/wp-json\/wp\/v2\/media?parent=14960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}